2020
DOI: 10.3389/fmed.2020.608441
|View full text |Cite
|
Sign up to set email alerts
|

FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway

Abstract: Background and Objective: Chemotherapy and radiotherapy are effective treatment options for cervical cancer (CC), but their efficacy is limited by short survival rate of about 5 years particularly for advance stage CC. Bioinformatics analysis combined with experimental in vivo and in vitro data can identify potential markers of tumorigenesis and cancer progression to improve CC prognosis and survival rate of the patients. This study aims to investigate the prognostic value of family with sequence similarity 83… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 41 publications
1
10
0
Order By: Relevance
“…Rong et al also indicated that FAM83A is regulated by miR-206 and promotes cervical cancer progression through the PI3K/AKT/mTOR pathway [13]. Liu et al proposed that FAM83A is involved in the occurrence and development of lung cancer and is related to poor prognosis [29].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Rong et al also indicated that FAM83A is regulated by miR-206 and promotes cervical cancer progression through the PI3K/AKT/mTOR pathway [13]. Liu et al proposed that FAM83A is involved in the occurrence and development of lung cancer and is related to poor prognosis [29].…”
Section: Discussionmentioning
confidence: 99%
“…FAM83A promotes tumor progression and increases proliferation, invasion, drug resistance, and stem cell-like traits in breast, lung, hepatocellular, and pancreatic cancers [5,[9][10][11][12]. A recent study indicated that FAM83A is regulated by miR-206 to promote cervical cancer development via the PI3K/AKT/ mTOR pathway [13]. Xu et al also reported that FAM83A was associated with cervical lesion progression and carcinogenesis and that it was specific for cervical cancer as opposed to cervical intraepithelial neoplasia (CIN) 2 to CIN 3 and normal cervical epithelium [14].…”
Section: Ivyspringmentioning
confidence: 99%
“…It was identified based on its transforming potential (35)(36)(37). FAM83A upregulation has been detected in multiple human tumor types, including breast, lung, pancreatic and cervical cancer (37)(38)(39)(40)(41)(42)(43)(44). Lee et al (45,46) revealed the ability of FAM83A to confer resistance to epidermal growth factor receptor/ tyrosine kinase inhibitors (EGFR-TKIs) through interactions with c-RAF and PI3K p85 in breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…The above research showed that the high expression of FAM83A/B/H in cervical cancer had important value in the occurrence, development, and prognosis evaluation of cervical cancer. In recent years, many studies have shown that FAM83A/B/H can activate MAPK, Wnt, and PI3K/AKT/mTOR signaling pathways in lung and pancreatic cancers [13,30,[34][35][36][37][61][62][63] and regulate tumor occurrence, development, and biological behavior. In order to better clarify the molecular mechanism, biological function, and related signal regulation network of FAM83A/B/H in cervical cancer, GO enrichment analysis on FAM83A/B/H and their closely related genes was performed, which revealed that the above genes were involved in the formation of cell-substrate junction, membrane raft, desmosome, and regulated various biological behaviors, including lipid binding, cadherin, and calcium-dependent protein binding, and regulating skin and epidermis development, in ammatory response and cell junction organization.…”
Section: Discussionmentioning
confidence: 99%